Navigation Links
New malaria vaccines roadmap targets next generation products by 2030
Date:11/14/2013

oth for protection against malaria disease and for malaria elimination. These include next-generation vaccines that target both Plasmodium falciparum and Plasmodium vivax species of malaria.

"The new vaccines should show at least 75 percent efficacy against clinical malaria, be suitable for use in in all malaria-endemic areas, and be licensed by 2030," says Dr Jean-Marie Okwo Bele, Director of WHO's Department of Immunization, Vaccines and Biologicals. "The roadmap also sets a target for malaria vaccines that reduce transmission of the parasite."

The 2013 Malaria Vaccine Technology Roadmap cites several reasons for the update, among them changing malaria epidemiology associated with the successful scale-up of malaria control measures in the last decade, a renewed focus on malaria elimination and eradication in addition to the ongoing need to sustain malaria control activities, and new technological innovations since 2006 including promising early work on so-called transmission-blocking malaria vaccines.

WHO lists 27 malaria vaccine candidates currently in clinical trials, with most in early stages of testing; RTS,S/AS01 is the only one currently in late-stage development.

The roadmap's vision centres on developing safe and effective vaccines against Plasmodium falciparum and Plasmodium vivax that prevent disease and death and prevent transmission to enable malaria eradication, and is built around two strategic goals:

  • Development of malaria vaccines with protective efficacy of at least 75 percent against clinical malaria suitable for administration to appropriate at-risk groups in malaria-endemic areas.
  • Development of malaria vaccines that reduce transmission of the parasite and thereby substantially reduce the incidence of human malaria infection. This will enable elimination in multiple settings. Vaccines to reduce transmission should be suitable for administration in mass campaigns.


'/>"/>

Contact: Dr. Vasee Moorthy
moorthyv@who.int
41-795-406-919
WHO
Source:Eurekalert

Page: 1 2

Related biology news :

1. Holograms offer hope in fight against malaria, study suggests
2. CWRU grants Disease Diagnostic Group option on malaria diagnostic device
3. NIH fellowship helps researcher fight malaria, understand mosquito immunity
4. Hand-held device cheaply, quickly diagnosis malaria
5. Quest for edible malarial vaccine leads to other potential medical uses for algae
6. Early warning system provides 4-month forecast of malaria epidemics in northwest India
7. New method for researching understudied malaria-spreading mosquitoes
8. New approach alters malaria maps
9. Young malaria parasites refuse to take their medicine, may explain emerging drug resistance
10. MVI and Inovio partner to develop malaria vaccines using innovative vaccine delivery tech
11. Penn team mimicking a natural defense against malaria to develop new treatments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
(Date:12/17/2014)... --Research and Markets ( http://www.researchandmarkets.com/research/9zq33j/global_chemical ) ... Chemical Sensor Market 2015-2019" report to their ... One major trend upcoming in this ... in biomedical applications. Chemical sensors help in recording ... during surgical procedures. The Global Chemical Sensor market ...
(Date:12/11/2014)... 10, 2014  That blood pressure plays a role in ... – the medical term for high blood pressure – was ... the inflatable cuff that,s used in measuring blood pressure was ... nothing new about hypertension, its triggers and its effects. In ... condition and the best ways to treat it. ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4
... breakthrough by detecting the electrical equivalent of a living ... closer to both seeing the ‘heartbeat?of a living cell ... To stay alive, individual biological cells must transfer electrically ... flow produces an electrical current that could, in principle, ...
... by a combination of both genetic and environmental factors. ... least 5?0 per cent of all cases of breast ... BRCA1 and BRCA2 only explain 20-30 per cent of ... contribution of additional susceptibility genes. According to Dr Robert ...
... has published the genome sequence of the rhesus macaque ... genomes. Published April 13 in a special section of ... primate species share about 93 percent of their DNA, ... In its paper, the Rhesus Macaque Genome Sequence and ...
Cached Biology News:A new study of living cells could revolutionize the way we test drugs 2Gene elevating breast cancer risk also causes prostate cancer 2Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps 2Analysis of rhesus monkey genome uncovers genetic differences with humans, chimps 3
(Date:12/22/2014)... , Dec. 22, 2014   Synthetic ... developer of pathogen-specific therapies for serious infections ... the microbiome, today announced positive topline safety ... clinical trial of SYN-004, the Company,s investigational ... Clostridium difficile (C. difficile) infection, ...
(Date:12/22/2014)... VIEJO, Calif. , Dec. 22, 2014  ( ... that CoPatient, an online medical bill review and advocacy ... offering in the FREE WellCard Savings discount health services ... medical bill that was more than they expected to ... members reduce health care costs, WellCard Savings is pleased ...
(Date:12/19/2014)... and Hershey, PA (PRWEB) December 19, 2014 ... BJCT), a leading developer and manufacturer of needle-free ... into an agreement with Immunomic Therapeutics, Inc. (“ITI”) ... needle-free injection device with its LAMP™ vaccine platform. ... option for an exclusive Worldwide license to the ...
(Date:12/19/2014)... Calif. , Dec. 19, 2014  Roche (SIX: ... of Bina Technologies, Inc. (Bina), a privately held ... , USA. Bina provides a big data ... generation sequencing (NGS) data. Bina,s proprietary on-market Genomic ... and academic researchers to perform fast and scalable ...
Breaking Biology Technology:Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3Roche acquires Bina Technologies and enters the genomic informatics market 2Roche acquires Bina Technologies and enters the genomic informatics market 3
... April 16 The Board of Managers of,Theranostics ... Danong Chen has,been elected as the new President ... the President and CEO of Tanox Inc., a ... in 2007.,Previously Dr. Chen was Vice-President of Strategy ...
... Building, CHARLESTON, S.C., April 16 The Medical ... Edwin and Barbara,Pearlstine Healing Garden. The healing garden, designed ... from Edwin S. Pearlstine, Jr., in memory,of his wife ... cancer in,1997., "Edwin and Barbara Pearlstine will forever ...
... April,23, 2008, GlaxoSmithKline plc will announce its first ... 31, 2008. The announcement is,scheduled to be released ... (ET) US and will be available on the ... announcement, JP Garnier, Chief Executive Officer and,Julian Heslop, ...
Cached Biology Technology:Danong Chen appointed CEO of Theranostics Health 2MUSC's Hollings Cancer Center Dedicates Edwin and Barbara Pearlstine Healing Garden Endowed with $1 Million Gift from Edwin S. Pearlstine, Jr. 2
...
... Cosmid Cloning Kit enables you to prepare, ... unbiased primary cosmid library of genomic DNA ... sublibraries. High efficiency cosmid library construction is ... protocols. First, genomic DNA is randomly sheared ...
Mouse monoclonal antibody raised against a partial recombinant AATK. NCBI Entrez Gene ID = AATK...
... Analyzer is a revolutionary multi-capillary electrophoresis system ... platform. It integrates sample loading, electrophoresis, and ... improving the workflow and increasing the productivity ... Benefits of using HDA system are:, ...
Biology Products: